Literature DB >> 14172076

VITILIGO IN A CASE OF VACCINIA VIRUS-TREATED MELANOMA.

K H BURDICK, W A HAWK.   

Abstract

Entities:  

Keywords:  GERIATRICS; MELANOMA; NEOPLASM IMMUNOLOGY; NEOPLASM METASTASIS; NEOPLASM REGRESSION, SPONTANEOUS; NEOPLASM THERAPY; PATHOLOGY; SKIN NEOPLASMS; SMALLPOX VACCINE; TRYPSIN; VACCINE THERAPY; VITILIGO

Mesh：

Substances：

Year:  1964        PMID： 14172076     DOI： 10.1002/1097-0142(196406)17:6<708::aid-cncr2820170604>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  19 in total

Review 1.  The role of immunotherapy in the management of patients with malignant melanoma.

Authors:  J E Goodnight; D L Morton
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

Review 2.  [The immunology of malignant melanoma (author's transl)].

Authors:  G Schieferstein
Journal:  Klin Wochenschr       Date:  1978-03-15

3.  Use of vaccinia virus in the treatment of metastatic malignant melanoma.

Authors:  I Hunter-Craig; K A Newton; G Westbury; B W Lacey
Journal:  Br Med J       Date:  1970-05-30

4.  [Studies on the effect of smallpox vaccine and Freund's adjuvant on the Harding-Passey melanoma in the mouse].

Authors:  B Schwab
Journal:  Arch Dermatol Forsch       Date:  1971

5.  Immunity to malignant disease in man.

Authors:  G H Fairley
Journal:  Br Med J       Date:  1969-05-24

6.  The effect of attenuated vaccinia virus AS strain on N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric cancer in rats.

Authors:  S Arakawa; K Fukai
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

7.  [Immunologic analysis of tyrosinase in malignant melanoma, nevi and clinically normal skin].

Authors:  W P Herrmann
Journal:  Arch Dermatol Forsch       Date:  1971

8.  Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma. Treatment of stage II melanoma with viral lysates.

Authors:  P Hersey; A Edwards; A Coates; H Shaw; W McCarthy; G Milton
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

9.  Infection of DBA/2 or C3H/HeJ mice by intraperitoneal injection of vaccinia virus elicits activated macrophages, cytolytic and cytostatic for S91-melanoma tumor cells.

Authors:  R J Natuk; J A Byrne; J A Holowczak
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

10.  Vitiliginous achromia with malignant melanoma. Tyrosinase activity and ultrastructural study of achromic and normal skin.

Authors:  H Perrot; J P Ortonne; D Schmitt
Journal:  Arch Dermatol Res       Date:  1977-01-31       Impact factor: 3.017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.